Universal Ibogaine

Universal Ibogaine wants to treat opioid addiction by opening 52 clinics before the end of 2025.

Universal Ibogaine

Universal Ibogaine is currently running a clinic in Mexico and upon regulatory drug approval, Universal Ibogaine intends to acquire and build a network of addiction treatment clinics across various global markets where the use of ibogaine is legal. The company have administered 3,500 doses of ibogaine at the clinic to date.

From their site: “Universal Ibogaine is a Canadian company poised to address the opioid epidemic through proven plant medicine. We will operate and franchise clinics with a safe and effective, seven-day treatment with ibogaine to deal with the opioid crisis, changing attitudes towards vibrant new medical solutions.”

Universal Ibogaine has raised a total of $87.2K in funding over 2 rounds. Their latest funding was raised on Oct 5, 2020, from a Seed round.

Key Staff

  • Jeremy Weate – CEO
  • James Richardson – CFO
  • William Dick – Chief Medical Advisor
  • Shayne Nyquvest – Chairman & Founder


Company Information

Universal Ibogaine Website

August, 2018


B2C Pharmaceutical Clinic

Topics of Interest

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office 595 Howe St #303, Vancouver, BC V6C 2T5, Canada